NEW YORK (GenomeWeb News) – The Alzheimer's Disease and Dementia Initiative at the New York Academy of Sciences and the Alzheimer's Drug Discovery Foundation and their corporate partners have awarded a $140,000 grant to fund researchers at Australia's Florey Institute of Neuroscience and Mental Health to validate a protein biomarker test for detecting Alzheimer's disease, NYAS said today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: mouse genome functional analysis, more sensitive chromatin immunoprecipitation, and more.

The Center for Data Innovation and HealthITNow argue for re-building of genomic research infrastructure.

A Senate committee has unanimously approved a bill to require articles resulting from federally funded projects to be made publicly available, according to ScienceInsider.

The US is heading toward another budget showdown, Nature News says.